Gabelli Downgrades Schiff Nutrition (SHF) to Hold

Go back to Gabelli Downgrades Schiff Nutrition (SHF) to Hold

Imperial Capital Downgrades Schiff Nutrition (SHF) to In-Line

November 1, 2012 11:19 AM EDT

Imperial Capital downgraded Schiff Nutrition (NYSE: SHF) from Outperform to In-Line with a price target of $34.00 (from $27.00) following takeover by Bayer HealthCare LLC.

"We do not believe Schiff will seek a competing offer; however, it does have the option to review unsolicited... More

DA Davidson Downgrades Schiff Nutrition (SHF) to Neutral

November 1, 2012 9:53 AM EDT

DA Davidson downgraded Schiff Nutrition (NYSE: SHF) from Buy to Neutral with a price target of $34.00 following the takeover of the company.

For an analyst ratings summary and ratings history on Schiff Nutrition... More

Bayer HealthCare LLC Buys Schiff Nutrition (SHF) for $34/Share

October 30, 2012 8:05 AM EDT

Schiff Nutrition International, Inc. (NYSE: SHF) agreed to be acquired by Bayer HealthCare LLC for approx. US$1.2 billion, or $34 per share in cash.

Closing is subject to customary closing conditions and is expected by year end 2012.

Schiff generated net sales of... More